The necessity of HIV testing in Iranian pregnant women and its ethical considerations
,
Abstract
A high number of HIV positive babies are born each year, whereas by highly effective preventive measures, the risk of mother-to-child transmission can be decreased significantly. There are different methods (for example mandatory versus voluntary) for HIV screening in pregnant women, but there are debates on conducting HIV testing by these methods. One of the most important issues in this field is its ethical considerations. Also its limitations cannot be ignored. According to these facts several keywords were searched by search engines such as Web of Sciences, Medline, Google scholar, WHO website. The most relevant and recent articles were chosen.
Concerning the importance of vertical transmission of HIV, the role of preventive measures, ethical considerations, and the limitations of HIV screening, we recommend HIV testing offer to every pregnant women at the first clinic visit by providing enough information for patient and considering her autonomy. Also policy makers should provide a guideline for this test according to the pregnant women's autonomy, confidentiality, and dignity.
Colembunders RL, Heywad WL. Surveillance of AIDS and HIV infection: opportunities and challenges. Health Policy 1990; 15: 1-11.
Karon JM, Rosenberg PS, Mcquillan G, et al. Prevalence of HIV infection in the US, 1984 to 1992. JAMA 1996; 276: 126-31.
Anonymous. Center for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2003 (volume 15).
www.cdc.gov/hiv/states/2003SurveillanceReport.pdf (accessed on Dec 2008)
Mertens TE, Low-Beer D. HIV and AIDS: where is the epidemic going? Bull World Health Organ 1996; 74(2): 121-9.
Anonymous. Prevalence of HIV/AIDS in Iran. http://www.iranhiv.com/epidemiology_iran.htm (accessed on Nov 2008).
Anonymous. The status of AIDS in Iran. http://www.irshafa.ir/post-3841.aspx (accessed on Dec 2008)
Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trial Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
Anonymous. World Health Organization (WHO). 2006. Antiretroviral therapy of HIV infection in infants and children:
towards universal access. Recommendations for a public health approach. NLM classification: WC 503.2. Geneva: WHO.
http://www.who.int/hiv/pub/guidelines/art/en/index.html (accessed on Dec 2008)
Myer L, Robkin M, Abrams EJ, et al. Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus initiative. Reprod Health Matters 2005;13: 136-46.
Anonymous. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Recomm Rep 2001; 50: 63-85.
Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to- child transmission of human immunodeficiency virus type1: the French prenatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 1996; 175: 661-7.
Nduati R. Breastfeeding and HIV-1 infection. A review of current literature. Adv Exp Med Biol 2000; 478: 201-10.
Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for prenatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Eng J Med 1999; 341: 385-93.
Shapiro DE, Sperling RS, Mandelbrot L, et al. Risk factors for prenatal human immunodeficiency virus transmission in
patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group. Obstet Gynecol
; 94: 897-908.
Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk for prenatal transmission. Women and Infants Transmission Study Group. N Eng J Med 1999; 341: 394- 402.
Anonymous. Mother-to-child transmission of human immunodeficiency virus in Italy: temporal trends and determinants of infection. The Italian Collaborative Study on HIV infection in pregnancy. Hum Reprod 1999; 14: 242-6.
Anonymous. HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study. AIDS 2001; 15: 761- 70.
Mofenson LM. Advances in the prevention of vertical transmission of human immunodeficiency virus. Semin Pediatr Infect Dis 2003; 14: 295-308.
Anonymous. U.S. Department of Health and Human Services. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1- infected women for maternal health and interventions to reduce prenatal HIV-1 transmission in the United States. 2005. http://aidsinfo.nih.gov/guidelines/perinatal/PER_022405.pdf (accessed on Dec 2008)
Dorenbaum A, Cunningham CK, Gelber RD, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce prenatal HIV transmission: a randomized trial. JAMA 2002; 288: 189-98.
Ioannidis JPA, Abrams EJ, Ammann A, et al. Prenatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. J Inf Dis 2001; 183: 539-45.
Walmsley S. Opt in or opt out: What is optimal for prenatal screening for HIV infection? CMAJ 2003; 168: 707-8.
Keenan-Lindsay L, Yudin MH. HIV screening in pregnancy. J Obstet Gynecol Can 2006; 28(12): 1103-7.
Heywood MJ. The routine offer of HIV counseling and testing: a human right. Health Hum Rights 2005; 8(2): 13-9.
Branson BM, Handsfield HH, Lampe MA, et al. Revised Recommendations for HIV Testing of Adults, Adolescents, and
Pregnant Women in Health-Care Settings. MMWR Recomm Rep 2006; 55(RR-14): 1-17.
Schûklenk U, Kleinsmidt A. Rethinking mandatory HIV testing during pregnancy in areas with high HIV prevalence rates: ethical and policy issues. Am J Public Health 2007; 97: 1179-83.
Anonymous. World Health Organization (WHO)/Joint United Nations Program on HIV/AIDS (UNAIDS). 2004. Policy
Statement on HIV Testing. Geneva: WHO/UNAIDS. http://www.who.int/hiv/pub/vct/en/hivtestingpolicy04.pdf (accessed on Dec 2008)
De Cock K, Mbori-Ngacha D, Marum E. Shadow on the Continent: Public Health and HIV/AIDS in Africa in the 21st
century. Lancet 2002; 360(9326): 67-72.
Anonymous. HIV testing among pregnant women-United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep 2002; 51: 1013-6.
Kiarie J, Nduati R, Koigi K, Musia J, John G. HIV-1 testing in pregnancy: acceptability and correlates of return for test
results. AIDS 2000; 14: 1468-70.
Anonymous. World Health Organization (WHO)/Joint United Nations Programme on HIV?AIDS (UNAIDS). 2006. WHO and UNAIDS Secretariat Statement on HIV Testing and Counseling. Geneva: WHO/UNAIDS.
http://data.unaids.org/pub/ExternalDocument/2007/20070905_rghr_statement_testing_en.pdf (accessed on Dec 2008)
Anonymous. World Health Organization (WHO)/Joint United Nations Program on HIV?AIDS (UNAIDS). 2007. Guidance on Provider-initiated HIV Testing and Counseling in Health Facilities. NLM classification: WC 503.1. Geneva: WHO/UNAIDS. http://www.who.int/hiv/who_pitc_guidelines.pdf (accessed on Dec 2008)
De Zulueta P, Boulton M. Routine antenatal HIV testing: the responses and perceptions of pregnant women and the viability of informed consent. A qualitative study. J Med Ethics 2007; 33: 329-36.
Rennie S, Behets F. Desperately seeking targets: the ethics of routine HIV testing in low-income countries. Bull World Health Organ 2006; 84: 52-57.
Clark PA. Mother-to-child transmission of HIV in Botswana: an ethical perspective on mandatory testing. Dev World Bioeth 2006; 6: 1-12.
Armstrong R. Mandatory HIV testing in Pregnancy: is there ever a time? Dev World Bioeth 2008; 8(1): 1-10.
Csete J, Elliott R. Scaling up HIV testing: human rights and hidden costs. HIV AIDS Policy Law Rev 2006; 11: 1, 5-10.
Vermund SH, Wilson CM. Barriers to HIV testing-where next? Lancet 2002; 360: 1186-7.
Cartoux M, Msellati P, Meda N, et al. Attitude of pregnant women towards HIV testing in Abidjan, Cote d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS049 Clinical Trial). Diminution de la Transmission Mere Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS 1998; 12: 2337-44.
Meadows J, Catalan J. Who do antenatal attenders decide to have the HIV antibody test? Int J STD AIDS 1994; 5: 400-4.
Royce AR, Walter EB, Fernandez I, et al. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health 2001; 91: 727-33.
Chou R, Smits AK, Huffman LH, Fu R, Korthulus PT. Prenatal Screening for HIV: a review of the evidence for the US
preventive services task force. Ann Intern Med 2005; 143: 38-54.
Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000; 355: 2237-44.
Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Eng J Med 1994; 331: 1173-80.
Anonymous. Epidemiological country profile on HIV and AIDS. http://www.who.int/globalatlas/predefinedReports/EFS2008/short/EFSCountryProfiles2008_IR.pdf (accessed on Nov 2008).
Anonymous. Guidance on global scale-up of the prevention of mother-to-child transmission of HIV.
http://www.who.int/hiv/pub/guidelines/pmtct_scaleup2007/en/index.html (accessed on Nov 2008).
Maitra N, Kavishvar AB, Dinkar A, Desai VA. Antenatal HIV testing. J Obstet Gynecol India 2006; 56(1): 56-8.
| Files | ||
| Issue | Vol 2 (2009) | |
| Section | Articles | |
| Keywords | ||
| HIV screening, Vertical transmission, Ethics, Autonomy, Human rights. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
